Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives
Teja Ram, Ankit Kumar Singh, Adarsh Kumar, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 10, pp. 1837-1857
Open Access | Times Cited: 17

Showing 17 citing articles:

Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS
Lin Li
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Glycosylation profiling of triple-negative breast cancer: clinical and immune correlations and identification of LMAN1L as a biomarker and therapeutic target
Qianru Yu, Hanyi Zhong, Xinhao Zhu, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Pumping the Breaks on Acantholytic Skin Disorders: Targeting Calcium Pumps, Desmosomes, and Downstream Signaling in Darier, Hailey–Hailey, and Grover Disease
Robert M. Harmon, Jessica Ayers, Erin F McCarthy, et al.
Journal of Investigative Dermatology (2024)
Closed Access | Times Cited: 2
Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation
Ying Yang, Na Suo, Shi-hao Cui, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 1
Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia
Maierbiya Abulimiti, Zheng-yi Jia, Yun Wu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 8, pp. 2797-2826
Closed Access | Times Cited: 1
Trametinib restores the central conducting lymphatic flow in a premature infant with Noonan syndrome
Erika Leenders, Lotte E. R. Kleimeier, Lauren C. Weeke, et al.
Clinical Case Reports (2024) Vol. 12, Iss. 7
Open Access | Times Cited: 1
MEK inhibitors in oncology: a patent review and update (2016 - present)
Anjali Suryavanshi, Vandana, Yugal Kishor Shukla, et al.
Expert Opinion on Therapeutic Patents (2024)
Closed Access | Times Cited: 1
Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: any place for drug repurposing?
Elisa Avolio, Barbara Bassani, Marzia Campanile, et al.
Pharmacological Reviews (2024), pp. 100033-100033
Open Access | Times Cited: 1
Progress in the development of ERK1/2 inhibitors for treating cancer and other diseases
Lena Grogan, Paul Shapiro
Advances in pharmacology (2024), pp. 181-207
Closed Access
ERK hyperactivation in epidermal keratinocytes impairs intercellular adhesion and drives Grover disease pathology
Cory L. Simpson, Afua Tiwaa, Shivam A. Zaver, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display KRAS and Extensive PTPN11/SHP2 Mutations and Respond In Vitro to MEK Inhibition by Cobimetinib
Ya-Ting Yang, Alexander I. Engleberg, I. J. Kapoor, et al.
Genes (2024) Vol. 15, Iss. 8, pp. 1050-1050
Open Access
Investigation and Characterization of the RAS/RAF/MEK/ERK Pathway and Other Signaling Pathways in Chronic Sinusitis with Nasal Polyps
Zhipu Niu, Jichao Sha, Dongdong Zhu, et al.
International Archives of Allergy and Immunology (2024), pp. 1-12
Closed Access
Transglutaminase 2 promotes epithelial-to-mesenchymal transition by regulating the expression of matrix metalloproteinase 7 in colorectal cancer cells via the MEK/ERK signaling pathway
Roman A. Blaheta, Jiaoyan Han, Elsie Oppermann, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 1, pp. 167538-167538
Open Access
Unveiling the Promise: Navigating Clinical Trials 1978–2024 for PDAC
A. Domínguez, M Perz, Yi Xu, et al.
Cancers (2024) Vol. 16, Iss. 21, pp. 3564-3564
Open Access
Investigates the Role of PANoptosis in Idiopathic Pulmonary Fibrosis and Potential Therapeutic Targets
Yunfei Xiang, Guang-Bin Huang, Can Luo, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 11605-11629
Open Access
Design, one-pot synthesis, computational and biological evaluation of diaryl benzimidazole derivatives as MEK inhibitors
Teja Ram, Ankit Kumar Singh, Prateek Pathak, et al.
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-16
Closed Access | Times Cited: 1
Antiviral and Immunomodulatory Effect of Zapnometinib in Animal Models and Hospitalized COVID-19 Patients
Yvonne Füll, Lara Maria Schüssele, Hazem Hamza, et al.
(2023)
Closed Access | Times Cited: 1
Page 1

Scroll to top